⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9051405 | 0.96 | TTR (0.36) | — | |
| SCHEMBL18165 | 0.96 | — | — | |
| SCHEMBL2771972 | 0.96 | TTR (0.36) | — | |
| Bromide SCHEMBL5069293 | 0.93 | — | — | |
| Hydrochloric Acid SCHEMBL1434836 | 0.93 | TTR (0.33) | — | |
| SCHEMBL14841784 | 0.93 | — | — | |
| Iodide SCHEMBL3075479 | 0.93 | — | — | |
| SCHEMBL9760083 | 0.93 | TTR (0.33) | — | |
| Hydrochloric Acid SCHEMBL4491180 | 0.93 | TTR (0.33) | — | |
| Hydrochloric Acid SCHEMBL17919 | 0.93 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2658851-B1 | HETEROCYCLIC COMPOUNDS SUITABLE FOR THE TREATMENT OF DYSLIPIDEMIA | CADILA HEALTHCARE LTD (IN) | 2015-03-11 | — | — | EP | disclosed |
| EP-2658851-A1 | HETEROCYCLIC COMPOUNDS SUITABLE FOR THE TREATMENT OF DYSLIPIDEMIA | Cadila Healthcare Limited (IN) | 2013-11-06 | — | — | EP | disclosed |
| WO-2012090220-A1 | HETEROCYCLIC COMPOUNDS SUITABLE FOR THE TREATMENT OF DYSLIPIDEMIA | CADILA HEALTHCARE LIMITED (IN) | 2012-07-05 | — | — | WO | disclosed |